ShareValue scores for 600572.SHG: Valuation 69, Quality 53, Growth 53, Health 58.

600572.SHG
SSE

Zhejiang CONBA Pharmaceutical Co Ltd

CN¥4.34(+2.36%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

8% to 18%
Valuation
69
Fair Value
Price vs Value
Quality
53
Moderate
Business Strength
Growth
53
Moderate
Revenue & Earnings
Health
58
Moderate
Financial Stability
Momentum
45
Neutral
Price Trend

Company Details

About

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it offers prescription pieces, formula granules, plant extracts, and other products. The company offers its products under Aokang, Jindi, Jinaikang, Qianliekang, Tianbaoning, Jinkang Su, Li, Zhixinyan, Kang Enbei, Baozhilin, and Yangyingtang brands. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026